Here we introduce a series of direct, potent and selective MCL-1 inhibitors that demonstrate clear on-target cellular activity, disrupting MCL-1–BIM protein complexes and triggering apoptosis in cancer cell lines shown to rely on MCL-1 for survival. This evidence concerns the gene MCL1 and cancer.